Gemcitabine in Combination with Oxaliplatin (GEMOX) As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma

被引：0

作者：

Ozdemir, Evren ^{[1
]}

Aslan, Alma ^{[1
]}

Turker, Alev ^{[1
]}

Barista, Ibrahim ^{[1
]}

Kars, Ayse ^{[1
]}

机构：

[1] Hacettepe Univ, Inst Canc, Dept Med Oncol, Ankara, Turkey

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
Schade, Jake R.
Kim, Charles
Drill, Esther
Qiu, Annie
Batlevi, Connie Lee
Caron, Philip
Colbourn, Donald Steven
Hamilton, Audrey
Hamlin, Paul A.
Horwitz, Steven M.
Intlekofer, Andrew M.
Joffe, Erel
von Keudell, Gottfried R.
Kumar, Anita
Noy, Ariela
Okwali, Michelle
Owens, Colette
Palomba, M. Lia
Rodriguez-Rivera, Ildefonso
Sauter, Craig S.
Schoder, Heiko
Straus, David J.
Vardhana, Santosha
Younes, Anas
Zelenetz, Andrew D.
Matasar, Matthew J.
BLOOD, 2019, 134
[22] Brentuximab vedotin followed by allogeneic transplantation as salvage regimen in patients with relapsed and/or refractory Hodgkin's lymphoma
Garciaz, Sylvain
Coso, Diane
Peyrade, Frederic
Fuerst, Sabine
Duran, Segolene
Chetaille, Bruno
Brenot-Rossi, Isabelle
Devillier, Raynier
Granata, Angela
Blaise, Didier
Bouabdallah, Reda
HEMATOLOGICAL ONCOLOGY, 2014, 32 (04) : 187 - 191
[23] Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma
Mendler, J. H.
Kelly, J.
Voci, S.
Marquis, D.
Rich, L.
Rossi, R. M.
Bernstein, S. H.
Jordan, C. T.
Liesveld, J.
Fisher, R. I.
Friedberg, J. W.
ANNALS OF ONCOLOGY, 2008, 19 (10) : 1759 - 1764
[24] Rituximab Plus Gemcitabine, Ifosfamide, Oxaliplatin (R-GIFOX), a New Effective Cytoreductive/Mobilizing Salvage Regimen for Relapsed and Refractory Hodgkin Lymphoma.
Corazzelli, Gaetano
Capobianco, Gaetana
Arcamone, Manuela
Becchimanzi, Cristina
Marcacci, Giampaolo
Frigeri, Ferdinando
Russo, Filippo
Pinto, Antonio
BLOOD, 2008, 112 (11) : 901 - 902
[25] Results of GROC-rev salvage regimen: Gemcitabine, rituximab, and oxaliplatin chemotherapy with revlimid for relapsed/refractory aggressive non-Hodgkin lymphoma (NHL).
Cabanillas, Fernando
Liboy, Idalia
Cruz, Alexis
Solivan, Pedro Gil
Rivera, Noridza
Pardo, Wandaly Ibis
Acosta, Mirelis
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[26] Gemcitabine, vinorelbine and dexamethasone: A safe and effective regimen for treatment of relapsed/refractory hodgkin's lymphoma
Ganesan, Prasanth
Mehra, Nikita
Joel, Anjana
Radhakrishnan, Venkatraman
Dhanushkodi, Manikandan
Kalayarasi, Jayachandran Perumal
Kannan, Krishnarathinam
Ganesan, Trivadi S.
Sagar, Tenali Gnana
LEUKEMIA RESEARCH, 2019, 84
[27] BRENTUXIMAB VEDOTIN PLUS BENDAMUSTINE AS A SALVAGE TREATMENT REGIMEN FOR PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA
LaCasce, A.
Bociek, G.
Sawas, A.
Caimi, P.
Agura, E.
Matous, J.
Ansell, S.
Crosswell, H.
Islas-Ohlmayer, M.
Behler, C.
Cheung, E.
Forero-Torres, A.
Vose, J.
O'Connor, O. A.
Josephson, N.
Advani, R.
HAEMATOLOGICA, 2016, 101 : 45 - 46
[28] Rituximab Plus Gemcitabine and Oxaliplatin as Salvage Therapy In Patients with Relapsed/Refractory Mantle-Cell Lymphoma
Gironella, Mercedes
Lopez, Andres
Pau, Abrisqueta
Anny, Jaramillo
Noelia, Purroy
Bosch, Francesc
BLOOD, 2010, 116 (21) : 1165 - 1165
[29] Rituximab Plus Gemcitabine and Oxaliplatin As Salvage Therapy in Patients with Relapsed/Refractory Mantle-Cell Lymphoma
Gironella, Mercedes
Lopez, Andres
Merchan, Brayan
Abrisqueta, Pau
Jaramillo, Anny
Bosch, Francesc
BLOOD, 2012, 120 (21)
[30] Ifosfamide, gemcitabine, and vinorelbine is an effective salvage regimen with excellent stem cell mobilization in relapsed or refractory pediatric Hodgkin lymphoma
Marr, Kristin
Ronsley, Rebecca
Nadel, Helen
Douglas, Kate
Gershony, Sharon
Strahlendorf, Caron
Davis, Jeffrey H.
Deyell, Rebecca J.
PEDIATRIC BLOOD & CANCER, 2020, 67 (04)

← 1 2 3 4 5 →